Recently published studies have demonstrated the adverse effects of inflammatory biomarkers associated with maternal obesity, such as C-reactive protein and leptin, on preterm birth, pre-eclampsia, and GDM [44]. This evidence concerns the gene LEP and gestational diabetes.